XBIO Financial Statements & Analysis
Complete financial statements for XBIO including income statement, balance sheet, and cash flow statement. Analyze XBIO's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
19.0% ↑
Net Income
32.3% ↑
Gross Margin
0.0% ↓
Operating Margin
43.4% ↑
Balance Sheet
Current Ratio
12.9% ↑
Debt to Equity
0.0% ↓
Asset Turnover
-1.8% ↓
Cash Flow
Operating Cash Flow
18.8% ↑
Net Cash Flow
161.0% ↑
Free Cash Flow
18.8% ↑
Cash Flow to Debt
18.8% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 2.50M | 2.98M | 19.0% | |
| Gross Profit | 2.50M | 2.98M | 19.0% | |
| Operating Income | -4.20M | -2.83M | 32.6% | |
| Net Income | -3.96M | -2.68M | 32.3% | |
| EPS | -2.57 | -1.58 | 38.5% | |
| EBITDA | -3.81M | -2.68M | 29.6% | |
| Gross Margin | 100.00% | 100.00% | 0.0% | |
| Operating Margin | -168.16% | -95.23% | 43.4% | |
| Net Income Margin | -158.39% | -90.07% | 43.1% | |
| R&D Expenses | 3.29M | 3.07M | 6.8% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.98M | 2.50M | 2.54M | — | — |
| Gross Profit | 2.98M | 2.50M | 2.54M | — | — |
| Operating Income | -2.83M | -4.20M | -4.52M | — | — |
| Net Income | -2.68M | -3.96M | -4.13M | — | — |
| EPS | -1.58 | -2.57 | -2.71 | — | — |
| EBITDA | -2.68M | -3.81M | -4.13M | — | — |
| Gross Margin | 100.00% | 100.00% | 100.00% | — | — |
| Operating Margin | -95.23% | -168.16% | -177.79% | — | — |
| Net Income Margin | -90.07% | -158.39% | -162.78% | — | — |
| R&D Expenses | 3.07M | 3.29M | 3.49M | — | — |
Financial Metrics
Want to dive deeper into XBIO's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics